Related Experiment Video

Updated: Aug 10, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

[Effect of perinatal inflammation syndrome on lung maturation and development]

T Lacaze-Masmonteil1, B Thébaud

  • 1Pédiatrie et Réanimation Néonatales, Hôpital Antoine-Béclère, AP/HP, 157, rue de la Porte-de-Trivaux, 92141 Clamart.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|March 10, 2001
PubMed

Insights

Inflammation in newborns may cause chronic lung disease, even without ventilation. Understanding this link is key to developing new treatments for very preterm infants and preventing bronchopulmonary dysplasia.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Immunology

Context:

  • Bronchopulmonary dysplasia (BPD) incidence remains high despite advances in neonatal care.
  • Chronic lung disease affects very premature infants, even those not requiring mechanical ventilation.
  • Inflammation, triggered prenatally or perinatally, is increasingly linked to chronic lung disease development.

Purpose:

  • To review evidence linking inflammation to chronic lung disease in neonates.
  • To explore the dual role of inflammatory mediators in lung maturation.
  • To identify knowledge gaps regarding inflammation's impact on alveolarization.

Summary:

  • Epidemiological, experimental, and clinical data suggest inflammation is a key factor in developing chronic lung disease.
  • Proinflammatory mediators can paradoxically aid lung maturation, complicating direct therapeutic targeting.
  • Further research is needed to elucidate how inflammation affects lung maturation and alveolar development.

Impact:

  • Highlights the critical role of the inflammatory response in neonatal chronic lung disease.
  • Suggests potential for novel immunomodulatory therapies to prevent lung disease in preterm infants.
  • Emphasizes the need for a nuanced understanding of inflammation's effects on developing lungs.

More Related Videos

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...